Browse > Article

Isolation of an Acinetobacter junii SY-01 Strain Producing an Extracellular Lipase Enantioselectively Hydrolyzing Itraconazole Precursor, and Some Properties of the Lipase  

Yoon, Moon-Young (Life Science Division, Korea Institute of Science and Technology)
Shin, Pyong-Kyun (Environment & Process Technology Division, Korea Institute of Science and Technology)
Han, Ye-Sun (Life Science Division, Korea Institute of Science and Technology)
Lee, So-Ha (Life Science Division, Korea Institute of Science and Technology)
Park, Jung-Keug (Department of Chemical and Biochemical Engineering, Dongguk University)
Cheong, Chan-Seong (Life Science Division, Korea Institute of Science and Technology)
Publication Information
Journal of Microbiology and Biotechnology / v.14, no.1, 2004 , pp. 97-104 More about this Journal
Abstract
Water-sludge bacteria were screened to find a lipase enantioselectively hydrolyzing itraconazole precursor, which is well known as the starting material of antifungal drug agents. A bacterial strain was isolated and identified as Acinetobacter junii SY-01. After the strain was cultivated, the enzyme was purified 39.4-fold using ultrafiltration and gel filtration through a Sephadex G-100 chromatographic column and the activity yield was 34.9%. The molecular weight of the enzyme was about 40 kDa, as measured by SDS-PAGE, and the optimum pH was 7.0- 9.0 and stable at pH 6.0- 9.0. The optimum temperature was 45- $5^{\circ}C$, and 73% of the enzymes activity remained after incubation at 70% for 1 h. Enzyme activity was enhanced by gall powder, sodium deoxycholate, a cationic detergent Tween 80, and a non-ionic detergent Triton X-100, but was markedly inhibited by metal ions such as $Hg^{2+},Cu^{2+},Ni^{2+}/,Ca^{2+}$, and an anionic-surfactant sodium dodecylsulfate. The $K_{m}$ values for (R)- and (S)-enantiomers of the itraconazole precursor were 0.385 and 21.83 mM, respectively, and the $V_{max} values ($\mu$Mㆍmin^{-1}.)$ were 6.73 and 6.49, respectively. The acetyl group among the different acyl moieties of itraconazole precursor showed the highest enantioselectivity for the hydrolysis by the Acinetobacter junii SY-01 lipase, and the lipase from Acinetobacter junii SY-01 displayed better enantioselectivity than that of commercially available lipases and esterases.
Keywords
Lipase; enantioselective; chiral; screening; activity;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 8  (Related Records In Web of Science)
연도 인용수 순위
1 Christopher, R., J. C. Raymond, S. A. Joseph, P. Victor, W. H. Frederick, G. Randolph, and C. Michel. 1997. Process development for the production of the (S)-acid precursor of a novel elastase inhibitor (L-694, 458) through the lipasecatalyzed kinetic resolution of a b-lactam benzyl ester. J. Ferm. Bioeng. 83: 48-53
2 Gerhardt, P. 1981. Manual of Methods for General Bacteriology, pp. 418. American Society for Microbiology, Washington, U.S.A
3 Hutt, A. J. and J. O’Grady. 1996. Drug chirality: A consideration of the significance of the stereochemistry of antimicrobial agents. J. Antimicrob. Chemotherap. 37: 7-32
4 Kaoru, N., K. Masamichi, and O. Atsuyoshi. 1995. Structure of solvent affects enantioselectivity of lipase-catalyzed transesterification. Tetrahedron 51: 8799-8808
5 Kim, C. S., I. S. Lee, N. H. Chung, and W. G. Bang. 2001. Optical resolution of DL-pipecolic acid by fermentation using Pseudomonas sp. PA09. J. Microbiol. Biotechnol. 11: 217-221
6 Matsumae, H., M. Furui, T. Shibatani, and T. Tosa. 1994. Production of optically active 3-phenylglycidic acid ester by the lipase from Serratia marcescens on a hollow-fiber membrane reactor. J. Ferment. Bioeng. 78: 59-63
7 Michael, A. J., P. L. David, and A. B. Lynne. 1995. Enantioselective hydrolysis of ethyl 2-hydroxyalkanoates by an extracellular esterase from a Bacillus sphaericus strain. Enzyme Microb. Technol. 17: 175-179
8 Santoniello, E., P. Ferraloschi, P. Grisent, and A. Monzouchi. 1992. The biocatalytic approach to the preparation of enantiomerically pure chiral building blocks. Chem. Rev. 92: 1071-1140
9 Shon, J. K., D. Tian, D. Y. Kwon, C. S. Jin, and T. J. Lee. 2002. Degradation of fat, oil, and grease (FOGs) by Lipaseproducing bacterium Pseudomonas sp. strain D2D3. J. Microbiol. Biotechnol. 12: 583-591
10 Beata, P., R. Justyna, and J. Plenkiewicz. 1998. Lipasecatalyzed kinetic resolution of the racemic mixtures of 1- aryloxy-3-nitrato-and 1-aryloxy-3-azido-2-propanols. Synthetic Communications 28: 4355-4364
11 Lee, E. G. and B. H. Chung. 2000. Chiral resolution using enzymes. Korean J. Biotechnol. Bioeng. 15: 415-422
12 Seu, Y. B., Y. C. Su, and K. D. Lee. 1996. Preparation of (S)- 3-acetoxy-2-methylpropanol with lipase. Kor. J. Appl. Microbiol. Biotechnol. 24: 213-216
13 Chen, C. H., Y. Fujimoto, G. Girdaukas, and C. J. Sih. 1982. Quantitative analysis of biochemical kinetic resolutions of enantiomers. J. Am. Chem. Soc. 104: 7294-7299
14 Eduardo, G. U., F. Rebolledo, and V. Gotor. 2001. Study of the enantioselectivity of the CAL-B-catalyzed transesterification of a-substituted $\alpha$-propylmethanols and a-substituted benzyl alcohols. Tetrahedron: Asymmetry 12: 3047-3052
15 Hou, C. T. and T. M. Johnston. 1992. Screening of lipase activities with cultures from the agricultural research services culture collection. JAOACS 69: 1088-1097
16 Jung, W. H., H.-K. Kim, C.-Y. Lee, and T.-K. Oh. 2002. Biochemical properties and substrate specificity of lipase from Staphylococcus aureus B56. J. Microbiol. Biotechnol. 12: 25-30
17 Laemmli, U. K. 1970. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227: 680-685   DOI   PUBMED   ScienceOn
18 Margolin, A. 1993. Enzymes in the synthesis of chiral drugs. Enzyme Microb. Technol. 15: 266-280
19 Jones, J. B. 1986. Enzymes in organic synthesis. Tetrahedron 42: 3351-3403   DOI   ScienceOn
20 Tietz, N. W. and E. A. Fiereck. 1966. A specific method for serum lipase determination. Clin. Chim. Acta 13: 352-355
21 Deutsch, D. H. 1991. Chiral drugs: The coming revolution. CHEMTECH 3: 157-159
22 Lowry, O. H., N. J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275
23 Niklas, O., C. Orrenius, A. Mattson, T. Norin, and K. Hult. 1996. Kinetic resolutions of amine and thiol analogues of secondary alcohols catalyzed by the Candida antarctica lipase B. Enzyme Microb. Technol. 19: 328-331   DOI   ScienceOn
24 Ahn, J. O., H. W. Jang, H. W. Lee, E. S. Choi, S. J. Haam, T. K. Oh, and J. K. Jung. 2003. Overexpression of thermoalkalophilic lipase from Bacillus stearothermophilus L1 in Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 13: 451-456   과학기술학회마을   ScienceOn
25 Gray, N. M. and R. L. Woosley. 1995. Methods and compositions of (2R, 4S) itraconazole for treating fungal yeast and dermatophyte infections. US Patent No. 5,474,997
26 Mohapatra, S. C. and J. T. Hsu. 1999. Optimizing lipase activity, enantioselectivity, and stability with medium engineering and immobilization for b-blocker synthesis. Biotech. Bioeng. 64: 213-220   DOI   ScienceOn
27 Lee, E. Y. and H. S. Kim. 2001. Development of hollowfiber reactor system for the production of chiral 1,2-epoxy-7- octene by microbial enantioselective hydrolysis reaction. Korean J. Biotechnol. Bioeng. 16: 259-263
28 Borman, S. 1992. FDA issues flexible policy on chiral drugs. Chem. Eng. News 6: 5-6
29 Federsel, H. J. 1993. Drug chirality-scale-up, manufacturing, and control. CHEMTECH 12: 24-33
30 Kim, Y. H., C. S. Cheong, S. H. Lee, S. J. Jun, K. S. Kim, and H. S. Cho. 2002. Lipase-catalyzed resolution of 1,3-dioxolane derivatives: Synthesis of a homochiral intermediate for antifungal agents. Tetrahedron: Asymmetry 13: 2501-2508
31 Kirchner, G., M. P. Scollar, and A. M. Klibanov. 1985. Resolution of racemic mixtures via lipase catalysis in organic solvents. J. Am. Chem. Soc. 107: 7072-7076
32 Ariens, E. J. 1993. Nonchiral, homochiral and composite chiral drugs. Trends Biochem. Sci. 14: 68-76
33 McCullough, J. R., C. H. Senanayake, G. J. Tanoury, Y. Hohg, and P. Koch. 1999. 2R, 4S, R, S- and 2S, 4R, R, SHydroxyitraconazole. US Patent No. 5,952,502